Innovate UK

The British company has announced the results of two studies showcasing the ability of its EpiSwitch platform to diagnose and stage breast cancer and ALS patients.

The firm has secured rights to use CRISPR in cell lines for biomanufacturing and will work with Solentim to increase editing throughput while decreasing costs.

The partners plan to develop a computational platform that automates pipelines and processes for biomarker discovery, drug recovery and repositioning, and more.

The national program to set up local innovation hubs will collaborate with regional experts in government, academia, and the healthcare industry.

The company is developing a search application that will allow users to explore genomic datasets without accessing sensitive information.

The consortium comprises Oxford BioDynamics,OxfordUniversityresearchers, and Chronos Therapeutics.

NEW YORK (GenomeWeb) – Horizon Discovery Group today announced it and life sciences measurement and testing firm LGC have received a £360,224 ($612,000) research grant to develop novel reference standard materials for clinical diagnostics.

NEW YORK (GenomeWeb News) – The UK government and economic development organizations in Scotland and Northern Ireland plan to invest up to £2.8 million ($4.6 million) to fund small businesses pursuing feasibility research projects, including those involving various omics and bioinformatics techno

NEW YORK (GenomeWeb News) – Enigma Diagnostics today announced a second grant from the UK's Technology Strategy Board to further develop the company's multidrug-resistant tuberculosis (MDR-TB) test on its Enigma Mini Laboratory system.

NEW YORK (GenomeWeb News) – Several UK government bodies plan to award up to £3.8 million ($6.1 million) in competitive grants to fund industry-led research and development projects to advance synthetic biology technologies, according to the Biotechnology and Biological Sciences Research Council.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.